Selective abnormalities of prefrontal serotonergic receptors in schizophrenia
Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleinman JE: Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. Arch Gen Psychiatry 1993; 50:810-818
Serotonin-2 binding sites in human frontal cortex and hippocampus: Selective loss of S-2A sites with age
Marcusson JO, Morgan DG, Winblad B, Finch CE: Serotonin-2 binding sites in human frontal cortex and hippocampus: selective loss of S-2A sites with age. Brain Res 1984; 311:51-56
No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET
Trichard C, Paillere-Martinot ML, Attar-Levy D, Blin J, Feline A, Martinot JL: No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET. Schizophr Res 1998; 31:13-17
Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: A positron emission tomography study with fluorine-18 labeled setoperone
Yatham LN, Liddle PF, Dennie J, Shiah IS, Adam MJ, Lane C, Lam RW, Ruth TJ: Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18 labeled setoperone. Arch Gen Psychiatry 1999; 56:705-711
Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis
Petit-Taboue MC, Landeau B, Osmont A, Tillet I, Barre L, Baron JC: Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis. J Nucl Med 1996; 37:95-104